Joy is the Senior Vice President of Elixiron Immunotherapeutics. In this role, she takes regulatory and clinical leadership for immunotherapeutic product development. Joy also engages in business development opportunity for international partnership and collaboration.
Joy has over 20 years’ experience in the biopharmaceutical industry with international experiences across Asia, the US and Europe. She has extensive product life cycle management from product development, clinical trial, commercialization to market authorization and post-marketing management.Joy started her career as a senior regulator with Center for Drug Evaluation, Taiwan where she evaluated clinical trial and market authorization for medicinal products of various therapeutic areas. In the industrial sector, Joy has several leadership roles of increasing responsibility at both large multinational and small companies. In Singapore, Joy held the positions of Head of Regulatory Affairs at 3M Health Care and Reckitt Benckiser Pharmaceuticals (now Indivior) for Asia Pacific Region and Emerging Markets. At Quintiles (now IQVIA), Joy served as the Director of Strategic Drug Development where she formulated product development strategy for clinical trial and market approval across Asia, the US and EU markets. Prior to joining Elixiron Immunotherapeutics, Joy was appointed the Vice President and Chief Operating Officer at V-Check, Inc. with a remit to lead global strategies to drive the commercialization and international partnership for a new diagnostic program.Joy received Ph.D. degree in Pharmacology from Washington State University, USA and completed post-doctoral training at University of Illinois. She also holds Executive MBA from National Taiwan University.